187 related articles for article (PubMed ID: 35817406)
41. Combination of long noncoding RNA
Wang WW; Zhou XL; Song YJ; Yu CH; Zhu WG; Tong YS
Onco Targets Ther; 2018; 11():2333-2344. PubMed ID: 29731641
[TBL] [Abstract][Full Text] [Related]
42. A novel diagnostic method for distinguishing parapneumonic effusion and empyema from other diseases by using the pleural lactate dehydrogenase to adenosine deaminase ratio and carcinoembryonic antigen levels.
Saraya T; Ohkuma K; Koide T; Goto H; Takizawa H; Light RW
Medicine (Baltimore); 2019 Mar; 98(13):e15003. PubMed ID: 30921217
[TBL] [Abstract][Full Text] [Related]
43. Cell-Free DNA Methylation Analysis as a Marker of Malignancy in Pleural Fluid.
Bixby B; Vrba L; Lenka J; Oshiro M; Watts GS; Hughes T; Erickson H; Chopra M; Knepler JL; Knox KS; Jarnagin L; Alalawi R; Kala M; Bernert R; Routh J; Roe DJ; Garland LL; Futscher BW; Nelson MA
Res Sq; 2023 Oct; ():. PubMed ID: 37886511
[TBL] [Abstract][Full Text] [Related]
44. Identification of differentially expressed miRNAs in differentiating benign from malignant pleural effusion.
Bao Q; Xu Y; Ding M; Chen P
Hereditas; 2020 Feb; 157(1):6. PubMed ID: 32102688
[TBL] [Abstract][Full Text] [Related]
45. Combined Methylation of
Zhong Q; Wang Y; Liang C; Wei F; She B
Discov Med; 2023 Oct; 35(178):845-852. PubMed ID: 37811622
[TBL] [Abstract][Full Text] [Related]
46. CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion.
Wang F; Yang L; Gao Q; Huang L; Wang L; Wang J; Wang S; Zhang B; Zhang Y
Cancer Immunol Immunother; 2015 Aug; 64(8):965-76. PubMed ID: 25944005
[TBL] [Abstract][Full Text] [Related]
47. Elevated Hsp90-beta contributes to differential diagnosis of pleural effusion caused by lung cancer and correlates with malignant biological behavior of lung cancer.
Biaoxue R; Min L; Tian F; Wenlong G; Hua L
BMC Pulm Med; 2018 Dec; 18(1):188. PubMed ID: 30522463
[TBL] [Abstract][Full Text] [Related]
48. Diagnostic Accuracy of Interleukin-27 between Tuberculous Pleural Effusion and Malignant Pleural Effusion: A Meta-Analysis.
Liu Q; Yu YX; Wang XJ; Wang Z; Wang Z
Respiration; 2018; 95(6):469-477. PubMed ID: 29539604
[TBL] [Abstract][Full Text] [Related]
49. mRNA markers associated with malignant pleural effusion.
Hsu SC; Chang SY; Hwang YT; Terng HJ; Tsai CL; Shen CH; Huang SK; Chian CF
Sci Rep; 2023 Apr; 13(1):6677. PubMed ID: 37095178
[TBL] [Abstract][Full Text] [Related]
50. Idiopathic Pleural Effusions: Characteristics and Discrimination From Cytology-Negative Malignant Pleural Effusions.
Park JE; Do YW; Lee DH; Lee SY; Lim JK; Choi SH; Seo HW; Yoo SS; Lee SY; Cha SI; Park JY; Lee J; Kim CH
Am J Med Sci; 2020 Sep; 360(3):236-242. PubMed ID: 32423747
[TBL] [Abstract][Full Text] [Related]
51. Clinical value of jointly detection serum lactate dehydrogenase/pleural fluid adenosine deaminase and pleural fluid carcinoembryonic antigen in the identification of malignant pleural effusion.
Zhang F; Hu L; Wang J; Chen J; Chen J; Wang Y
J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27976800
[TBL] [Abstract][Full Text] [Related]
52. A Multicancer Malignant Pleural Effusion Diagnostic Test Using Hexokinase 2 and Single-Cell Sequencing.
Chen J; Yang Y; Wang Z; Shen X; Zhang Z; Wang C; Xu H; Shi Q
Clin Chem; 2022 May; 68(5):680-690. PubMed ID: 35142335
[TBL] [Abstract][Full Text] [Related]
53. [Evaluation of the diagnosis value of carcinoembryonic antigen in malignant pleural effusion].
Yu YX; Tong ZH; Zhou XX; Liang LR; Wang Z; Xu LL; Wang XJ; Wu YB; Li HJ; Lu Z
Zhonghua Yi Xue Za Zhi; 2018 Feb; 98(6):432-435. PubMed ID: 29429254
[No Abstract] [Full Text] [Related]
54. [Value of PET/MRI in the diagnosis of malignant pleural effusion in comparison with PET/CT].
Peng WB; Sun X; Zhou M; Wei XS; Wu XZ; Ruan WW; Shi HZ; Lan XL; Zhou Q
Zhonghua Yi Xue Za Zhi; 2021 Aug; 101(30):2363-2369. PubMed ID: 34404128
[No Abstract] [Full Text] [Related]
55. Label-Free Quantitative Proteomics Identifies Novel Biomarkers for Distinguishing Tuberculosis Pleural Effusion from Malignant Pleural Effusion.
Pan L; Zhang X; Jia H; Huang M; Liu F; Wang J; Du B; Wei R; Sun Q; Xing A; Li Q; Zhang Z
Proteomics Clin Appl; 2020 Jan; 14(1):e1900001. PubMed ID: 31715074
[TBL] [Abstract][Full Text] [Related]
56. Combining clinical and analytical parameters improves prediction of malignant pleural effusion.
Valdés L; San-José E; Ferreiro L; González-Barcala FJ; Golpe A; Álvarez-Dobaño JM; Toubes ME; Rodríguez-Núñez N; Rábade C; Lama A; Gude F
Lung; 2013 Dec; 191(6):633-43. PubMed ID: 24085319
[TBL] [Abstract][Full Text] [Related]
57. Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion.
Han HS; Yun J; Lim SN; Han JH; Lee KH; Kim ST; Kang MH; Son SM; Lee YM; Choi SY; Yun SJ; Kim WJ; Lee OJ
Int J Cancer; 2013 Aug; 133(3):645-52. PubMed ID: 23354517
[TBL] [Abstract][Full Text] [Related]
58. Diagnostic Values of sVEGFR-1 and Endostatin in Malignant Pleural Effusions in Patients with Lung Cancer.
Zhu YY; Wu HM; Liu RY
Clin Lab; 2017 Sep; 63(9):1371-1378. PubMed ID: 28879702
[TBL] [Abstract][Full Text] [Related]
59. Exploring the value of pleural fluid biomarkers for complementary pleural effusion disease examination.
Thi Huyen P; Li M; Li L; Ma S; Zhao Y; Yan J; Wang Z; Zhao M; Sun X
Comput Biol Chem; 2021 Oct; 94():107559. PubMed ID: 34412001
[TBL] [Abstract][Full Text] [Related]
60. Diagnostic and prognostic significance of receptor-binding cancer antigen expressed on SiSo cells in lung-cancer-associated pleural effusion.
Yang J; Zhu Y; Wu L; Zhu W; Zhang X; Yang Y; Xu C
Clin Respir J; 2018 Jan; 12(1):279-284. PubMed ID: 27402224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]